Ongoing Clinical Trials

Institution
Principal Investigator
Protocol Title
Keyword
TMU-JIRB No. Protocol Title Institution / Principal Investigator Type of Study Phases of Clinical Trials for Drugs
N202610048 A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Renal Outcomes and Mortality in Participants with Chronic Kidney Disease (Elevate-CKD) New Drug Phase Ⅲ
N202610068 A randomized, open-label (unblinding), crossover bioequivalence study to compare two 60 mg raloxifene HCl F.C. tablets in healthy subjects under fasted state. Bioavailability / Bioequivalence (BA/BE) NA
1 2 25 26 27 28 29 30 31 32 33 34 / 34

TOP